Skip to main content

Eiger BioPharmaceuticals, Inc.

EIGRDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001305253

Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.

Members of Congress who traded EIGR

No member of Congress has reported a trade in Eiger BioPharmaceuticals, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.